OBJECTIVE: Intensity-modulated radiotherapy (IMRT) for anal canal carcinoma (ACC) is associated with favourable toxicity outcomes. Side effects include sexual dysfunction, skin desquamation, pain and fibrosis to perineum and genitalia region. The genitalia are situated anterior to the primary ACC between two inguinal regions providing a challenging structure to avoid. Techniques improving outcomes require robust, consistent genitalia contouring to ensure standardization and production of fully optimized IMRT plans. Official recommendations for genitalia contouring are lacking. We describe a potential genitalia contouring atlas for ACC radiotherapy. METHODS: Following a review of genitalia CT anatomy, a contouring atlas was generated for male and female patients positioned prone and supine. Particular attention was paid to the reproducibility of the genitalia contour in all planes. RESULTS: Male and female genitalia positioned prone and supine are described and represented visually through a contouring atlas. Contoured areas in males include penis and scrotum, and in females include clitoris, labia majora and minora. The muscles, bone, prostate, vagina, cervix and uterus should be excluded. The genitalia contour extends laterally to inguinal creases and includes areas of fat and skin anterior to the symphysis pubis for both genders. CONCLUSION: This atlas provides descriptive and visual guidance enabling more consistent genitalia delineation for both genders when prone and supine. The atlas can be used for other sites requiring radiotherapy planning. ADVANCES IN KNOWLEDGE: This atlas presents visual contouring guidance for genitalia in ACC radiotherapy for the first time. Contouring methods provide reproducible genitalia contours that allow the provision of accurate dose toxicity data in future studies.
OBJECTIVE: Intensity-modulated radiotherapy (IMRT) for anal canal carcinoma (ACC) is associated with favourable toxicity outcomes. Side effects include sexual dysfunction, skin desquamation, pain and fibrosis to perineum and genitalia region. The genitalia are situated anterior to the primary ACC between two inguinal regions providing a challenging structure to avoid. Techniques improving outcomes require robust, consistent genitalia contouring to ensure standardization and production of fully optimized IMRT plans. Official recommendations for genitalia contouring are lacking. We describe a potential genitalia contouring atlas for ACC radiotherapy. METHODS: Following a review of genitalia CT anatomy, a contouring atlas was generated for male and female patients positioned prone and supine. Particular attention was paid to the reproducibility of the genitalia contour in all planes. RESULTS: Male and female genitalia positioned prone and supine are described and represented visually through a contouring atlas. Contoured areas in males include penis and scrotum, and in females include clitoris, labia majora and minora. The muscles, bone, prostate, vagina, cervix and uterus should be excluded. The genitalia contour extends laterally to inguinal creases and includes areas of fat and skin anterior to the symphysis pubis for both genders. CONCLUSION: This atlas provides descriptive and visual guidance enabling more consistent genitalia delineation for both genders when prone and supine. The atlas can be used for other sites requiring radiotherapy planning. ADVANCES IN KNOWLEDGE: This atlas presents visual contouring guidance for genitalia in ACC radiotherapy for the first time. Contouring methods provide reproducible genitalia contours that allow the provision of accurate dose toxicity data in future studies.
Authors: Brian G Czito; Joseph M Pepek; Jeffrey J Meyer; Sua Yoo; Christopher G Willett Journal: Oncology (Williston Park) Date: 2009-11-15 Impact factor: 2.990
Authors: Jose G Bazan; Wendy Hara; Annie Hsu; Pamela A Kunz; James Ford; George A Fisher; Mark L Welton; Andrew Shelton; Daniel S Kapp; Albert C Koong; Karyn A Goodman; Daniel T Chang Journal: Cancer Date: 2011-02-01 Impact factor: 6.860
Authors: Michael T Milano; Ashesh B Jani; Karl J Farrey; Carla Rash; Ruth Heimann; Steven J Chmura Journal: Int J Radiat Oncol Biol Phys Date: 2005-10-01 Impact factor: 7.038
Authors: Rob Glynne-Jones; David Sebag-Montefiore; Richard Adams; Alec McDonald; Simon Gollins; Roger James; John M A Northover; Helen M Meadows; Mark Jitlal Journal: Int J Radiat Oncol Biol Phys Date: 2010-10-08 Impact factor: 7.038
Authors: Prajnan Das; Scott B Cantor; Crystal L Parker; Joan B Zampieri; Andrew Baschnagel; Cathy Eng; Marc E Delclos; Sunil Krishnan; Nora A Janjan; Christopher H Crane Journal: Cancer Date: 2010-02-15 Impact factor: 6.860
Authors: Roger D James; Robert Glynne-Jones; Helen M Meadows; David Cunningham; Arthur Sun Myint; Mark P Saunders; Timothy Maughan; Alec McDonald; Sharadah Essapen; Martin Leslie; Stephen Falk; Charles Wilson; Simon Gollins; Rubina Begum; Jonathan Ledermann; Latha Kadalayil; David Sebag-Montefiore Journal: Lancet Oncol Date: 2013-04-09 Impact factor: 41.316
Authors: V Dell'Acqua; J Kobiela; F Kraja; M C Leonardi; A Surgo; M A Zerella; S Arculeo; C Fodor; R Ricotti; M G Zampino; S Ravenda; G Spinoglio; R Biffi; A Bazani; R Luraschi; S Vigorito; P Spychalski; R Orecchia; R Glynne-Jones; B A Jereczek-Fossa Journal: Med Oncol Date: 2018-03-28 Impact factor: 3.064
Authors: Deborah C Marshall; Elizabeth S Tarras; Ayesha Ali; Julie Bloom; Mylin A Torres; Jenna M Kahn Journal: CA Cancer J Clin Date: 2022-03-17 Impact factor: 286.130
Authors: Hendrik Dapper; Markus Oechsner; Stefan Münch; Christian Diehl; Jan C Peeken; Kai Borm; Stephanie E Combs Journal: Strahlenther Onkol Date: 2020-02-03 Impact factor: 3.621
Authors: William Tyler Turchan; Ritu Arya; Robert Hight; Hania Al-Hallaq; Michael Dominello; Dan Joyce; Bradley P McCabe; Anne R McCall; Eugenia Perevalova; Christopher Stepaniak; Kamil Yenice; Jay Burmeister; Daniel W Golden Journal: J Appl Clin Med Phys Date: 2020-09-28 Impact factor: 2.243